Connection

Paul O'Brien to Head and Neck Neoplasms

Back to Details
This is a "connection" page, showing publications Paul O'Brien has written about Head and Neck Neoplasms.
Paul O'Brien
Connection Strength
0.364
Head and Neck Neoplasms
  1. Molecular targets in squamous cell carcinoma of the head and neck. Curr Treat Options Oncol. 2007 Jun; 8(3):239-51.
    View in: PubMed
    Score: 0.193
  2. Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial. Clin Cancer Res. 2019 02 15; 25(4):1156-1164.
    View in: PubMed
    Score: 0.107
  3. Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C18-ceramide as a novel biomarker for monitoring response. Clin Cancer Res. 2011 Sep 15; 17(18):6097-105.
    View in: PubMed
    Score: 0.064
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.